Bacterial genomes pave the way to novel vaccines

Current Opinion in Microbiology

Volumn 7, Issue 3, 2004, Pages 314-320

  Meinke, Andreas ^a   Henics, Tamas ^a   Nagy, Eszter ^a  

^a INTERCELL AG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; VACCINE; VIRULENCE FACTOR;

ANALYTIC METHOD; BACTERIAL GENOME; BACTERIAL INFECTION; BIOINFORMATICS; COMPARATIVE STUDY; DISEASE SEVERITY; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; IMMUNOGENICITY; IN SITU HYBRIDIZATION; INFECTION SENSITIVITY; MICROBIAL ACTIVITY; MUTAGENESIS; NONHUMAN; PATHOGENESIS; PROTEOMICS; REVIEW; VELOCITY;

BACTERIAL INFECTIONS; BACTERIAL VACCINES; COMPUTATIONAL BIOLOGY; DRUG DESIGN; GENE EXPRESSION PROFILING; GENOME, BACTERIAL; GENOMICS; HUMANS; MUTAGENESIS; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 2942587063     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2004.04.008     Document Type: Review

References (52)

1. Zagursky RJ, Russell D: Bioinformatics: Use in Bacterial Vaccine Discovery. In BioComputing: Computer Tools for Biologists. Edited by Brown SM. Eaton Publishing; 2003:261-285.
2. Adu-Bobie J., Capecchi B., Serruto D., Rappuoli R., Pizza M. Two years into reverse vaccinology. Vaccine. 21:2003;605-610
3. Lei B., Liu M., Chesney G.L., Musser J.M. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: Purification and characterization of 16 Putative extracellular lipoproteins. J Infect Dis. 189:2004;79-89
4. Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O., Peterson J., DeBoy R., Dodson R., Gwinn M., Haft D., et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 184:2002;5479-5490
5. Cockle P.J., Gordon S.V., Lalvani A., Buddle B.M., Hewinson R.G., Vordermeier H.M. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect Immun. 70:2002;6996-7003
6. Ariel N., Zvi A., Grosfeld H., Gat O., Inbar Y., Velan B., Cohen S., Shafferman A. Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun. 70:2002;6817-6827
7. Tettelin H., Masignani V., Cieslewicz M.J., Eisen J.A., Peterson S., Wessels M.R., Paulsen I.T., Nelson K.E., Margarit I., Read T.D., et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci USA. 99:2002;12391-12396 An excellent example of how DNA array-based genome comparison supports vaccine development by depicting candidates that are conserved among different serotypes.
8. Mayers C., Duffield M., Rowe S., Miller J., Lingard B., Hayward S., Titball R.W. Analysis of known bacterial protein vaccine antigens reveals biased physical properties and amino acid composition. Comp Func Genom. 4:2003;468-478
9. De Groot A.S., Sbai H., Aubin C.S., McMurry J., Martin W. Immuno-informatics: Mining genomes for vaccine components. Immunol Cell Biol. 80:2002;255-269
10. Flower D.R. Towards in silico prediction of immunogenic epitopes. Trend Immunol. 24:2003;667-674
11. Conway T., Schoolnik G.K. Microarray expression profiling: capturing a genome-wide portrait of the transcriptome. Mol Microbiol. 47:2003;879-889
12. Merrell D.S., Butler S.M., Qadri F., Dolganov N.A., Alam A., Cohen M.B., Calderwood S.B., Schoolnik G.K., Camilli A. Host-induced epidemic spread of the cholera bacterium. Nature. 417:2002;642-645 One of the first examples of transcriptional profiling of an important pathogen, directly isolated from diseased individuals.
13. Voyich J.M., Sturdevant D.E., Braughton K.R., Kobayashi S.D., Lei B., Virtaneva K., Dorward D.W., Musser J.M., DeLeo F.R. Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci USA. 100:2003;1996-2001
14. Fisher M.A., Plikaytis B.B., Shinnick T.M. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J Bacteriol. 184:2002;4025-4032
15. Grifantini R., Bartolini E., Muzzi A., Draghi M., Frigimelica E., Berger J., Ratti G., Petracca R., Galli G., Agnusdei M., et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol. 20:2002;914-921 The authors demonstrate the power of transcriptional profiling to identify vaccine candidates inducing protective immune responses from a selected pool of meningococcal genes that are differentially regulated upon host-cell contact.
16. Grifantini R., Bartolini E., Muzzi A., Draghi M., Frigimelica E., Berger J., Randazzo F., Grandi G. Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development. Ann N Y Acad Sci. 975:2002;202-216
17. Kurz S., Hubner C., Aepinus C., Theiss S., Guckenberger M., Panzner U., Weber J., Frosch M., Dietrich G. Transcriptome-based antigen identification for Neisseria meningitidis. Vaccine. 21:2003;768-775
18. Grifantini R., Sebastian S., Frigimelica E., Draghi M., Bartolini E., Muzzi A., Rappuoli R., Grandi G., Genco C.A. Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B. Proc Natl Acad Sci USA. 100:2003;9542-9547
19. Smoot J.C., Barbian K.D., Van Gompel J.J., Smoot L.M., Chaussee M.S., Sylva G.L., Sturdevant D.E., Ricklefs S.M., Porcella S.F., Parkins L.D., et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA. 99:2002;4668-4673
20. Perrin A., Bonacorsi S., Carbonnelle E., Talibi D., Dessen P., Nassif X., Tinsley C. Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species. Infect Immun. 70:2002;7063-7072
21. Angelichio M.J., Camilli A. In vivo expression technology. Infect Immun. 70:2002;6518-6523
22. Marra A., Asundi J., Bartilson M., Lawson S., Fang F., Christine J., Wiesner C., Brigham D., Schneider W.P., Hromockyj A.E. Differential fluorescence induction analysis of Streptococcus pneumoniae identifies genes involved in pathogenesis. Infect Immun. 70:2002;1422-1433
23. Schneider W.P., Ho S.K., Christine J., Yao M., Marra A., Hromockyj A.E. Virulence gene identification by differential fluorescence induction analysis of Staphylococcus aureus gene expression during infection-simulating culture. Infect Immun. 70:2002;1326-1333
24. Finelli A., Gallant C.V., Jarvi K., Burrows L.L. Use of in-biofilm expression technology to identify genes involved in Pseudomonas aeruginosa biofilm development. J Bacteriol. 185:2003;2700-2710
25. Mason K.M., Munson R.S. Jr., Bakaletz L.O. Nontypeable Haemophilus influenzae gene expression induced in vivo in a chinchilla model of otitis media. Infect Immun. 71:2003;3454-3462
26. Mecsas J. Use of signature-tagged mutagenesis in pathogenesis studies. Curr Opin Microbiol. 5:2002;33-37
27. Kavermann H., Burns B.P., Angermüller K., Odenbreit S., Fischer W., Melchers K., Haas R. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med. 197:2003;813-822 This work represents the first systematic application of transposon mutagenesis to identify H. pylori genes that are essential for colonization in a relevant in vivo model.
28. Geoffroy M.C., Floquet S., Metais A., Nassif X., Pelicic V. Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis. Genome Res. 13:2003;391-398
29. Akerley B.J., Rubin E.J., Novick V.L., Amaya K., Judson N., Mekalanos J.J. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc Natl Acad Sci USA. 99:2002;966-971
30. Sassetti C.M., Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA. 100:2003;12989-12994
31. Forsyth R.A., Haselbeck R.J., Ohlsen K.L., Yamamoto R.T., Xu H., Trawick J.D., Wall D., Wang L., Brown-Driver V., Froelich J.M., et al. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol. 43:2002;1387-1400
32. Zhang Y.Q., Ren S.X., Li H.L., Wang Y.X., Fu G., Yang J., Qin Z.Q., Miao Y.G., Wang W.Y., Chen R.S., et al. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol. 49:2003;1577-1593
33. Zhu H., Bilgion M., Snyder M. Proteomics. Annu Rev Biochem. 72:2003;783-812
34. Klade C.S. Proteomics approaches towards antigen discovery and vaccine development. Curr Opin Mol Ther. 3:2002;216-223
35. Haas G., Karaali G., Ebermayer K., Metzger W.G., Lamer S., Zimny-Arndt U., Diescher S., Goebel U.B., Vogt K., Roznowski A.B., et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics. 2:2002;313-324 This work represents a large-scale effort to define disease-specific antigenic fingerprints of an important human pathogen.
36. Bumann D., Holland P., Siejak F., Koesling J., Sabarth N., Lamer S., Zimny-Arndt U., Jungblut P.R., Meyer T.F. A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening. Infect Immun. 70:2002;6494-6498
37. Montigiani S., Falugi F., Scarselli M., Finco O., Petracca R., Galli G., Mariani M., Manetti R., Agnusdei M., Cevenini R., et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun. 70:2002;368-379
38. Sabarth N., Lamer S., Zimny-Arndt U., Jungblut P.R., Meyer T.F., Bumann D. Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J Biol Chem. 277:2002;27896-27902
39. Vytvytska O., Nagy E., Bluggel M., Meyer H.E., Kurzbauer R., Huber L.A., Klade C.S. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics. 2:2002;580-590
40. Ariel N., Zvi A., Makarova K.S., Chitlaru T., Elhanany E., Velan B., Cohen S., Friedlander A.M., Shafferman A. Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun. 71:2003;4563-4579
41. Hughes M.J., Moore J.C., Lane J.D., Wilson R., Pribul P.K., Younes Z.N., Dobson R.J., Everest P., Reason A.J., Redfern J.M., et al. Identification of major outer surface proteins of Streptococcus agalactiae. Infect Immun. 70:2002;1254-1259
42. Sabarth N., Hurwitz R., Meyer T.F., Bumann D. Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy. Infect Immun. 70:2002;6499-6503
43. Etz H., Minh D.B., Henics T., Dryla A., Winkler B., Triska C., Boyd A.P., Sollner J., Schmidt W., von Ahsen U., et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA. 99:2002;6573-6578 The authors describe a novel platform technology for the genome-wide identification of antigens by using small-insert bacterial display peptide libraries in combination with human serum antibodies as selection reagents, and provide rapid validation strategy without the need for high-throughput recombinant protein expression.
44. Henics T., Winkler B., Pfeifer U., Gill S.R., Buschle M., von Gabain A., Meinke A. Small fragment genomic libraries for the display of putative epitopes of pathogens with high medical importance. BioTechniques. 35:2003;196-202
45. Nagy E, Henics T, von Gabain, A, and Meinke A: Identification of the 'antigenome' - a novel tool for design and development of subunit vaccines against bacterial pathogens. In Genomics, Proteomics, and Vaccines, Edited by Grandi G. John Wiley & Sons, Inc.; 2004:223-243.
46. Weichhart T., Horky M., Sollner J., Gangl S., Henics T., Nagy E., Meinke A., von Gabain A., Fraser C.M., Gill S.R., et al. Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect Immun. 71:2003;4633-4641
47. Hang L., John M., Asaduzzaman M., Bridges E.A., Vanderspurt C., Kirn T.J., Taylor R.K., Hillman J.D., Progulske-Fox A., Handfield M., et al. Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc Natl Acad Sci USA. 100:2003;8508-8513
48. Kim Y.R., Lee S.E., Kim C.M., Kim S.Y., Shin E.K., Shin D.H., Chung S.S., Choy H.E., Progulske-Fox A., Hillman J.D., et al. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect Immun. 71:2003;5461-5471
49. Ivey F.D., Magee D.M., Woitaske M.D., Johnston S.A., Cox R.A. Identification of a protective antigen of Coccidioides immitis by expression library immunization. Vaccine. 21:2003;4359-4367
50. Fachado A., Rodriguez A., Molina J., Silverio J.C., Marino A.P., Pinto L.M., Angel S.O., Infante J.F., Traub-Cseko Y., Amendoeira R.R., et al. Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii. Infect Immun. 71:2003;5407-5411
51. Almazan C., Kocan K.M., Bergman D.K., Garcia-Garcia J.C., Blouin E.F., de la Fuente J. Identification of protective antigens for the control of Ixodes scapularis infestations using cDNA expression library immunization. Vaccine. 21:2003;1492-1501
52. Delcayre A., Peake J.S., White D.J., Yuan S., McDonald M.K., Liang A., Tan P.L., Watson J.D. A genome-based functional screening approach to vaccine development that combines in vitro assays and DNA immunization. Vaccine. 21:2003;3259-3264 In this paper, a comprehensive approach is described, in which vaccine candidates from M. tuberculosis are identified by relying on in vivo protection in a relevant animal model as selection criteria. This approach involves immunization with plasmid pools that are pre-selected in in vitro functional assays.